Brief: Evonik Invests $100 Million In Its U.S. Drug Substance Contract Manufacturing Site
08/07/2026 13:04
BRIEF-Evonik Invests $100 Million In Its U.S. Drug Substance Contract Manufacturing Site July 8 (Reuters) - EVONIK INDUSTRIES AG EVKn.DE:
TO INVEST US$100 MILLION TO UPGRADE ITS U.S. DRUG SUBSTANCE CONTRACT MANUFACTURING SITE
Source text: ID:nPre8f4p3a
Further company coverage: [EVKn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Evonik Industries AG
See all newsBrief: Evonik Invests $100 Million In Its U.S. Drug Substance Contract Manufacturing Site
German chemical industry confidence improves sharply in June, Ifo says (updated)
German chemical sector gets temporary lift from Middle East disruptions, Ifo says
Evonik raise full-year outlook as Middle East disruption hits Asian rivals (updated)
Evonik raises full-year profitability outlook after Q2 beat